MS

Medha Singh

thechronicleherald.ca

An experienced stocks correspondent working at a reputed global news agency, adept with simplifying the day-to-day complexities of U.S. and European markets. Skilled with spotting and analyzing trends in a high-pressure environment to churn out timely market wraps. Also experienced in covering Emerging Markets (EMEA and Latin America region).

I like catching up on the latest findings in the field of neuroscience and psychology in my spare time.

Covers

Publications

  • reuters.com
    6 articles
  • amny.com
    3 articles
  • Reuters
    3 articles
  • thechronicleherald.ca
    3 articles
  • unionleader.com
    2 articles
  • yahoo.com
    2 articles
  • oann.com
    1 article

Writes Most On

SP500IndexReutersNASDAQEasternTimeZoneWallStreetFuturesContractCoronavirusETDonaldTrumpDowJonesIndustrialAverageDJIFederalReserveSystemChinaVirusPandemicBangaloreNasdaqCompositeStimulusGlobePetroleumUnitedStatesCentralBankIranNewYorkStockExchangeWashingtonSPDROrdersOfMagnitudeRecessionHealthCareNYSEVaccineEDTUnitedAirlinesMiddleEastUnemploymentBenefitsNewYorkAirstrikeGreenwichMeanTimeIraqRealEstateIntercontinentalExchangeMarketSentimentEconomicGrowthAustralianLaborPartyElectronicTradingBrexitUnitedStatesSecretaryOfTheTreasuryBankStockQasemSoleimani
  • —Reuters
  • AI lending firm Upstart jumps as $2 billion funding crushes short sellers
    10 May 2023—yahoo.com
    By Medha Singh (Reuters) -Shares of highly shorted Upstart Holdings Inc are on track for their best day in more than two years, squeezing bearish investors, after the artificial intelligence-driven lending marketplace secured an additional $2 billion in funding. The company's stock jumped 35% on Wednesday. San Mateo, California-based Upstart, which uses AI to verify and process loans quickly, said it would receive the capital from new and existing partners over the next 12 months, helping the...
  • S&P stumbles as Moderna sinks on report questioning trial results
    19 May 2020—reuters.com
    NEW YORK (Reuters) - The S&P 500 closed lower on Tuesday, as investors focused on a report questioning Moderna's recent coronavirus vaccine early-stage trial results, wiping out modest gains on the benchmark index in the last hour of trading. Major averages fell to session lows in the wake of a report from STAT News that questioned the validity of the results of Moderna's vaccine trial, which the company had announced Monday. Moderna Inc shares plunged after the report, and closed down...
  • Wall Street climbs on stimulus hopes, as S&P, Nasdaq hit multi-month highs
    20 May 2020—reuters.com
    NEW YORK (Reuters) - The three major averages on Wall St. notched their fourth gain in five sessions on Wednesday as investors again bet on a swift economic recovery from coronavirus-driven lockdowns and the potential for more stimulus measures from the Federal Reserve. The S&P 500 stands at a two-month high and was briefly above its 100-day moving average, a closely watched technical indicator that has acted as a resistance level. The Nasdaq finished at its highest close in three months and...
  • Oil jump lifts Wall Street as jobless claims data surges
    2 Apr 2020—reuters.com
    (Reuters) - U.S. stocks rallied on Thursday as hopes for a truce in the price war between Saudi Arabia and Russia and a cut in oil output drove gains, taking some sting out of a shocking jump in Americans filing jobless claims due to coronavirus-led lockdowns. The S&P energy index <.SPNY>, down by more than 50% this year due to the Russia-Saudi price war and coronavirus-driven demand worries that has caused oil prices to plunge, climbed 9.08%. Saudi Arabia has called for an emergency meeting...

People Also Viewed